Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rostami

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Scientific Reports|January 21, 2022
A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposureAli A Rostami, Jerry L Campbell, Yezdi B Pithawalla, et al.
Scientific Reports|February 9, 2022
Author Correction: A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposureAli A Rostami, Jerry L Campbell, Yezdi B Pithawalla, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 5, 2016
Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patientsM J E Brill, P A J Välitalo, A S Darwich, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 25, 2020
Comparison of experimentally measured and computational fluid dynamic predicted deposition and deposition uniformity of monodisperse solid particles in the Vitrocell® AMES 48 air-liquid-interface in-vitro exposure systemMichael J Oldham, Nicolas Castro, Jingjie Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 25, 2020
Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo projectB Abrahamsson, M McAllister, P Augustijns, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2020
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysisA Rostami, S M Riahi, H R Gamble, et al.
The Journal of Hospital Infection|June 12, 2023
Global incidence of surgical site infections following caesarean section: a systematic review and meta-analysisM Farid Mojtahedi, M Sepidarkish, M Almukhtar, et al.
Clinical Pharmacology and Therapeutics|February 10, 2017
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the futureA S Darwich, K Ogungbenro, A A Vinks, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 6, 2013
Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiToH Lennernäs, L Aarons, P Augustijns, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Scientific Reports|January 21, 2022
A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposureAli A Rostami, Jerry L Campbell, Yezdi B Pithawalla, et al.
Scientific Reports|February 9, 2022
Author Correction: A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposureAli A Rostami, Jerry L Campbell, Yezdi B Pithawalla, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 5, 2016
Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patientsM J E Brill, P A J Välitalo, A S Darwich, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 25, 2020
Comparison of experimentally measured and computational fluid dynamic predicted deposition and deposition uniformity of monodisperse solid particles in the Vitrocell® AMES 48 air-liquid-interface in-vitro exposure systemMichael J Oldham, Nicolas Castro, Jingjie Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 25, 2020
Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo projectB Abrahamsson, M McAllister, P Augustijns, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2020
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysisA Rostami, S M Riahi, H R Gamble, et al.
The Journal of Hospital Infection|June 12, 2023
Global incidence of surgical site infections following caesarean section: a systematic review and meta-analysisM Farid Mojtahedi, M Sepidarkish, M Almukhtar, et al.
Clinical Pharmacology and Therapeutics|February 10, 2017
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the futureA S Darwich, K Ogungbenro, A A Vinks, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 6, 2013
Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiToH Lennernäs, L Aarons, P Augustijns, et al.
Pageof 20